RPX2003

biapenem · Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RPX2003, covering 2012-12-03 to 2012-12-03. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics of Intravenous RPX2003 (Biapenem) in Healthy Adult Subjects [Phase 1]